Delivery Order SPE2DB24D3015-SPE2DB25FFYVL

Award Date 4/7/25
Potential Completion Date 4/28/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.12 firm fixed-price delivery order is for INGREZZA 40 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 Firm Fixed Price Delivery Order contract is for the supply of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $14,213.24 to AmerisourceBergen Drug Corp for the supply of 4,563,906,336 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The contract has an ultimate completion date of March 29, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). This contract is a task order under a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.12 contract is for the delivery of 4,568,077,962 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The contract has an ultimate completion date of May 20, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order worth $3,119.55 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty medication. The award has an ultimate completion date of December 20, 2022. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
This contract award, valued at $7,352.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567308258 INGREZZA 40 MG CAPSULE 30S, a specialty medication, with a completion date of March 12, 2025. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,119.55 firm fixed price delivery order is for the supply of INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of February 6, 2023 and was awarded on January 13, 2023. This order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.31, is for the delivery of 4565242920 INGREZZA 40 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $3,553.31 to AmerisourceBergen Drug Corp for the supply of 4565714078 - INGREZZA 40 MG CAPSULE 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has a final...
This federal contract award is a delivery order valued at $7,106.64 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4564222276 - INGREZZA 40 MG CAPSULE 30S, with a performance period ending on April 30, 2024. The contract is a firm fixed-price arrangement and does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFYVL
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $4,049.61 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567823738 ! INGREZZA 60 MG CAPSULE 30S. This contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order award is one of many federal contract awards that AmerisourceBergen has received from the DLA and other agencies, demonstrating the company's critical role in supplying medical products to the U.S. government.

Generated 7/7/25, 1:00 PM